Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • sebl
    Member
    • Mar 2014
    • 26

    How much DNA contamination "allowed"?

    Hi,

    We're going to do a RNA-SEQ experiment (with Nextseq 500) with bacterial RNA for differential gene expression. We have cells lysed and frozen in TRIZOL, and now we're using ZYMO's Direct-Zol kit to extract and purify RNA. DNAse I was used in column (20 min. at ~28 oC). After elution, samples were tested in QUBIT using dsDNA broad range reagent, and we got 2-3 micrograms/mL of DNA. RNA concentrations read in Nanodrop are about 80 micrograms/mL.

    The question is, should we worry about traces of DNA in the samples? How much DNA contamination is "allowed" in RNA samples for RNA-SEQ, without interfering with results?

    If there's anyone using similar reagents, we'd be glad to hear about modifications of the protocol, say, longer DNAse I treatment etc.

    By the way, we had other samples extracted and purified with the same protocol that we tested for DNA contamination using PCR (before we got QUBIT), and we detected no amplicons. We are yet to test the current samples with PCR.

    Thanks.
  • sebl
    Member
    • Mar 2014
    • 26

    #2
    I should mention that we'll use ScriptSeq Complete Kit from Epicentre to deplet rRNA and build RNA libraries.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
      by SEQadmin2


      Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

      The systematic characterization of the human proteome has
      ...
      07-20-2026, 11:48 AM
    • SEQadmin2
      Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
      by SEQadmin2



      Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
      ...
      07-09-2026, 11:10 AM
    • SEQadmin2
      Cancer Drug Resistance: The Lingering Barrier to Rising Survival
      by SEQadmin2



      Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

      There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
      07-08-2026, 05:17 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 07-20-2026, 11:10 AM
    0 responses
    18 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-13-2026, 10:26 AM
    0 responses
    32 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-09-2026, 10:04 AM
    0 responses
    43 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-08-2026, 10:08 AM
    0 responses
    29 views
    0 reactions
    Last Post SEQadmin2  
    Working...